Litcius/Paper detail

GM-CSF Programs Hematopoietic Stem and Progenitor Cells During Candida albicans Vaccination for Protection Against Reinfection

Cristina Bono, Paula Guerrero, Antonio Jordán‐Pla, Ana Erades, Nathan Salomonis, H. Leighton Grimes, M. Luisa Gil, Alberto Yáñez

2021Frontiers in Immunology19 citationsDOIOpen Access PDF

Abstract

live vaccine mouse model we show that vaccination protects mice against a secondary infection and increases the number of bone marrow, and especially, splenic trained monocytes. Moreover, vaccination expands and reprograms hematopoietic stem and progenitor cells (HSPCs) early during infection and mobilize them transiently to the spleen to produce trained macrophages. Trained HSPCs are not only primed for myeloid cell production but also reprogramed to produce a greater amount of proinflammatory cytokines in response to a second challenge. Additionally, their adoptive transfer is sufficient to protect mice against reinfection. Mechanistically, autocrine GM-CSF activation of HSPCs is responsible for the trained phenotype and essential for the vaccine-induced protection. Our findings reveal a fundamental role for HSPCs in the trained immune protective response, opening new avenues for disease prevention and treatment.

Topics & Concepts

HaematopoiesisImmunologyAdoptive cell transferProgenitor cellStem cellVaccinationBiologyBone marrowImmune systemSpleenMyeloidProinflammatory cytokineImmunityT cellCell biologyInflammationImmune responses and vaccinationsSARS-CoV-2 and COVID-19 ResearchDiabetes and associated disorders
GM-CSF Programs Hematopoietic Stem and Progenitor Cells During Candida albicans Vaccination for Protection Against Reinfection | Litcius